ARGNF (argenx SE) Total Tax Payable : $0 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is argenx SE Total Tax Payable?

argenx SE's Total Tax Payable for the quarter that ended in Sep. 2024 was $0 Mil.

argenx SE's quarterly Total Tax Payable increased from Mar. 2024 ($0 Mil) to Jun. 2024 ($14 Mil) but then declined from Jun. 2024 ($14 Mil) to Sep. 2024 ($0 Mil).

argenx SE's annual Total Tax Payable declined from Dec. 2021 ($4 Mil) to Dec. 2022 ($3 Mil) but then increased from Dec. 2022 ($3 Mil) to Dec. 2023 ($4 Mil).

argenx SE Total Tax Payable Historical Data

The historical data trend for argenx SE's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Total Tax Payable Chart

argenx SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

0.39

3.50

4.32

3.18

4.33

argenx SE Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	4.33	-	13.95	-

argenx SE Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

argenx SE Total Tax Payable Related Terms

Thank you for viewing the detailed overview of argenx SE's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (OTCPK:ARGNF) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

ARGX:USA ARGX:Mexico ARGXb:UK 0QW0:UK 1AE:Germany A1RG34:Brazil ARGX:Belgium

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.